Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
Eastern Cooperative Oncology Group
Kaiser Permanente
Washington University School of Medicine
City of Hope Medical Center
University of Nebraska
Eli Lilly and Company
Var2 Pharmaceuticals